VV Future ApS
Nøgletal
- Afkastningsgrad
- –
- Egenkapitalforrentning
- –
- Likviditetsgrad
- 54,7 %
- Soliditetsgrad
- -82,7 %
Resultat
| Regnskabsperiode | |
|---|---|
Bruttoresultat | -17.225 |
Finansielle indtægter | 854 |
Finansielle omkostninger | 974 |
Skat af årets resultat | 0 |
Årets resultat | -17.345 |
Balance
| Regnskabsperiode | |
|---|---|
Likvider | 334 |
Kortfristede aktiver | 18.267 |
Aktiver i alt | 18.267 |
Egenkapital | -15.108 |
Forpligtelser i alt | 33.375 |
Kortfristede forpligtelser | 33.375 |
Arbejdskapital
| Regnskabsperiode | |
|---|---|
Anden kortfristet gæld | 15.000 |
Kapital og udbytte
| Regnskabsperiode | |
|---|---|
Selskabskapital | 40.000 |
Overført resultat | -55.108 |
Højdepunkter fra årsrapporten
Forretning og udvikling
The company's purpose is distribution and trade of innovative medical and pharmaceutical protective equipment and related business.
Financial review
The company's income statement for the year ended 31 December 2022 shows a loss of DKK 17.345, and the balance sheet at 31 December 2022 shows negative equity of DKK 15.108.
Risici og væsentlige forhold
The company has lost more than 50% of its capital. The equity is expected to be restored i 2023 by means of capital increase.
The capital increase will ensure that the company will be able to continue its activities in 2023 and beyond.
Consequently, Management has presented its financial statements based on the assumption of a continued operation (the going concern principle).
No events have occurred after the balance sheet date which could significantly affect the company's financial position.
Forpligtelser og sikkerhedsstillelser
The company is jointly taxed with its parent company, CTNN ApS (management company), and has limited and secondary liability together with other jointly taxed entities for payment of income taxes as well as for payment of withholding taxes on dividends, interest and royalties.
Se op til 9 års regnskabshistorik ved at oprette en gratis bruger
Opret gratis bruger